Eisai (United States)
Eisai Co., Ltd. is a Japanese pharmaceutical company headquartered in Tokyo, Japan. It has some 10,000 employees, among them about 1,500 in research. Eisai is listed on the Tokyo Stock Exchange and is a member of the Topix 100 and Nikkei 225 stock indices. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Eisai (United States), United States, covering academic research published from 2000 to 2023. Read More.
Open Access Percentage
53%
Total
Publications
1.9K
Total Open
Publications
1K
Total
Citations
60K
Open Access
Percentage
53%
Total
Publications
1.9K
Total Open
Publications
1K
Total
Citations
60K
Breakdown
Publisher Open
25%
Both
22%
Other Platform Open
6%
Closed
47%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 23%
205
Hybrid 46%
409
No Guarantees 31%
282
Other Platform Open
Domain 87%
463
Institution 20%
109
Other Internet 8%
40
Public 7%
39
Preprint 2%
12
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 464 |
Europe PMC | Domain | 226 |
DOI | Other Internet | 50 |
Figshare | Public | 45 |
University College London - UCL Discovery | Institution | 24 |
Semantic Scholar | Public | 24 |
University of California - eScholarship University of California | Institution | 8 |
The University of Glasgow - Enlighten: Publications | Institution | 8 |
KU Leuven - Lirias | Institution | 8 |
bioRxiv | Preprint | 8 |